Literature DB >> 19072736

Two-dimensional gel-based approaches for the assessment of N-Linked and O-GlcNAc glycosylation in human and simian immunodeficiency viruses.

David R M Graham1, Megan J Mitsak, Steven T Elliott, Dawn Chen, Stephen A Whelan, Gerald W Hart, Jennifer E Van Eyk.   

Abstract

The glycosylation state of envelope glycoproteins in human and simian immunodeficiency viruses (HIV/SIV) is critical to viral infectivity and tropism, viral protein processing, and in virus evasion of the immune system. Using a rapid fluorescent 2-D gel-based method coupled with enzymatic pre-treatment of virus with PNGase F (Peptide: N-Glycosidase F) and fluorescent 2-D gels or 2-D gel Western blotting, we show significant differences in the glycosylation patterns of two SIV strains widely used in animal models of HIV disease and vaccine studies. We also demonstrate the modification of a host protein important in HIV biology (HLA-DR) by O-GlcNAc. Further, this experimental pipeline allows for the identification of the modified protein and the site of N-linked glycosylation by fluorescent 2-DE coupled with MS and the qualitative and semi-quantitative assessment of viral glycosylation. The method is fully compatible with downstream glycomics analysis. This approach will permit correlation of virus glycosylation status with pathological severity and may serve as a rapid screen of viruses from physiological samples for further study by more advanced MS methodology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19072736      PMCID: PMC2785494          DOI: 10.1002/pmic.200800608

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  65 in total

Review 1.  Primate models of AIDS.

Authors:  S V Joag
Journal:  Microbes Infect       Date:  2000-02       Impact factor: 2.700

2.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

Authors:  Andrew Keller; Alexey I Nesvizhskii; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2002-10-15       Impact factor: 6.986

3.  CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/DR5-mediated apoptosis.

Authors:  Jean-Philippe Herbeuval; Jean-Charles Grivel; Adriano Boasso; Andrew W Hardy; Claire Chougnet; Matthew J Dolan; Hideo Yagita; Jeffrey D Lifson; Gene M Shearer
Journal:  Blood       Date:  2005-07-26       Impact factor: 22.113

4.  DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus.

Authors:  S Pöhlmann; F Baribaud; B Lee; G J Leslie; M D Sanchez; K Hiebenthal-Millow; J Münch; F Kirchhoff; R W Doms
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

Review 5.  HIV-1 fitness and disease progression: insights from the SIV-macaque model.

Authors:  Jason T Kimata
Journal:  Curr HIV Res       Date:  2006-01       Impact factor: 1.581

6.  Cyanovirin-N, a potent human immunodeficiency virus-inactivating protein, blocks both CD4-dependent and CD4-independent binding of soluble gp120 (sgp120) to target cells, inhibits sCD4-induced binding of sgp120 to cell-associated CXCR4, and dissociates bound sgp120 from target cells.

Authors:  T Mori; M R Boyd
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

7.  Antibody neutralization and escape by HIV-1.

Authors:  Xiping Wei; Julie M Decker; Shuyi Wang; Huxiong Hui; John C Kappes; Xiaoyun Wu; Jesus F Salazar-Gonzalez; Maria G Salazar; J Michael Kilby; Michael S Saag; Natalia L Komarova; Martin A Nowak; Beatrice H Hahn; Peter D Kwong; George M Shaw
Journal:  Nature       Date:  2003-03-20       Impact factor: 49.962

8.  Infectivity of titered doses of simian immunodeficiency virus clone E11S inoculated intravenously into rhesus macaques (Macaca mulatta).

Authors:  R E Benveniste; S T Roodman; R W Hill; W B Knott; J L Ribas; M G Lewis; G A Eddy
Journal:  J Med Primatol       Date:  1994 Feb-May       Impact factor: 0.667

9.  Structural characterization by chromatographic profiling of the oligosaccharides of human immunodeficiency virus (HIV) recombinant envelope glycoprotein gp120 produced in Chinese hamster ovary cells.

Authors:  T Mizuochi; M W Spellman; M Larkin; J Solomon; L J Basa; T Feizi
Journal:  Biomed Chromatogr       Date:  1988-11       Impact factor: 1.902

10.  Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions.

Authors:  S Modrow; B H Hahn; G M Shaw; R C Gallo; F Wong-Staal; H Wolf
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

View more
  10 in total

1.  Biomarkers of HIV-1-associated neurocognitive disorders: challenges of proteomic approaches.

Authors:  Pawel Ciborowski
Journal:  Biomark Med       Date:  2009-12       Impact factor: 2.851

2.  The conserved set of host proteins incorporated into HIV-1 virions suggests a common egress pathway in multiple cell types.

Authors:  Michael E Linde; David R Colquhoun; Ceereena Ubaida Mohien; Thomas Kole; Veronica Aquino; Robert Cotter; Nathan Edwards; James E K Hildreth; David R Graham
Journal:  J Proteome Res       Date:  2013-03-29       Impact factor: 4.466

3.  Altered myofilament stoichiometry in response to heart failure in a cardioprotective α-myosin heavy chain transgenic rabbit model.

Authors:  Brian A Stanley; David R Graham; Jeanne James; Megan Mitsak; Patrick M Tarwater; Jeff Robbins; Jennifer E Van Eyk
Journal:  Proteomics Clin Appl       Date:  2011-03-01       Impact factor: 3.494

4.  An improved protocol for N-glycosylation analysis of gel-separated sialylated glycoproteins by MALDI-TOF/TOF.

Authors:  Piliang Hao; Yan Ren; Yongming Xie
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

5.  A universal chemical enrichment method for mapping the yeast N-glycoproteome by mass spectrometry (MS).

Authors:  Weixuan Chen; Johanna M Smeekens; Ronghu Wu
Journal:  Mol Cell Proteomics       Date:  2014-04-01       Impact factor: 5.911

Review 6.  Proteomic analysis of HIV-infected macrophages.

Authors:  Loyda M Meléndez; Krystal Colon; Linda Rivera; Eillen Rodriguez-Franco; Dianedis Toro-Nieves
Journal:  J Neuroimmune Pharmacol       Date:  2010-12-14       Impact factor: 4.147

7.  O-GlcNAc profiling: from proteins to proteomes.

Authors:  Junfeng Ma; Gerald W Hart
Journal:  Clin Proteomics       Date:  2014-03-05       Impact factor: 3.988

8.  Multiplexed Detection of O-GlcNAcome, Phosphoproteome, and Whole Proteome within the Same Gel.

Authors:  Caroline Cieniewski-Bernard; Erwan Dupont; Barbara Deracinois; Matthias Lambert; Bruno Bastide
Journal:  Front Endocrinol (Lausanne)       Date:  2014-10-28       Impact factor: 5.555

Review 9.  Host proteome research in HIV infection.

Authors:  Lijun Zhang; Xiaojun Zhang; Qing Ma; Honghao Zhou
Journal:  Genomics Proteomics Bioinformatics       Date:  2010-03       Impact factor: 7.691

10.  Natural Variation of Hazelnut Allergenicity: Is There Any Potential for Selecting Hypoallergenic Varieties?

Authors:  Miguel Ribeiro; Joana Costa; Isabel Mafra; Sandra Cabo; Ana Paula Silva; Berta Gonçalves; Mélanie Hillion; Michel Hébraud; Gilberto Igrejas
Journal:  Nutrients       Date:  2020-07-16       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.